echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Health yuan hits new inhaler medicine again!

    Health yuan hits new inhaler medicine again!

    • Last Update: 2021-04-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 3, the new drug category 2.


    Figure 1: Healthyuan’s application status of aclidinium bromide inhalation powder

    Source: CDE official website

    Table 1: The status of key inhalant products declared by Joincare and its subsidiaries earlier

    Source: Meinenet MED2.


    According to data from Meinenet.


    Figure 2: The latest clinical situation of some new inhalation drugs of Health Yuan

    Source: China Drug Clinical Trial Publicity Library of Meinenet

    Among the 9 clinically approved inhalation products, 4 are registered as new drugs.


    In addition, the clinical application of category 3 imitation of mometasone formoterol inhalation aerosol is under review and approval.


    At present, Joincare’s inhalation product line continues to have new products entering the clinical and market stage.


    Source: CDE official website, Minet database

    The review data statistics are as of April 6.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.